« News & Press Releases

VIVITRO LABS EXPANDS ADVISORY BOARD, ADDS EUROPEAN INDUSTRY EXPERTS TO THE TEAM

April 21st, 2016

Share on FacebookTweet about this on TwitterShare on LinkedIn

VICTORIA, B.C., April 21, 2016— ViVitro Labs announces additional industry leaders have joined its advisory board and strategic planning team to support ViVitro’s global growth and broadened cardiovascular device testing applications.

Dr. Ivan Vesely, Vascular Product Technical Specialist at BSI, and noted heart valve scientist formerly from The Cleveland Clinic, joins the ViVitro Labs business advisory board.

“Dr. Vesely brings extensive experience in areas key to ViVitro’s future plans including heart valves, device testing, and new product development for medical devices. He is a strong complement to our current advisors, Dr. John Webb and Dr. Mano Thubrikar,” explains Gerry Wight, ViVitro Labs GM.

In addition to expanding the Vivitro Labs business advisory board, the two principals of PROTOMEDLABS SAS, ViVitro Labs sales agent for Europe, Africa, and Israel, will add their extensive industry experience to ViVitro product applications and strategic direction initiatives. Karim Mouneimne, President, and Vincent Garitey PhD, Vice President of Engineering, will work directly with the ViVitro Labs team to create new products and services that meet the expanding need for cardiovascular repair device testing, simulation and training. PROTOMEDLABS SAS will remain an independent sales agent with Messrs. Mouneimne and Garitey retaining their respective leadership positions.

“We are seeing new opportunities in an expanding market,” notes Gerry Wight. “To leverage these opportunities we are heading in a new strategic direction that will open new markets and enable us to bring new testing products to market. To ensure we meet our customers’ requirements we are very pleased to have the experience and industry knowledge that Karim and Vincent have to guide us in developing these new products and introducing them to the global marketplace.”

About Dr. Ivan Vesely
Dr. Vesely is recognized internationally for his work in heart valves. Prior to founding ValveXchange he was an Endowed Professor at the University of Southern California, and prior to that, he founded the Cleveland Clinic’s heart valve laboratory and built it into the best-funded valve laboratory in the world. At ValveXchange, Dr. Vesely invented and developed the exchangeable heart valve and also served as the company’s Chief Science and Technology Officer. Dr. Vesely previously founded Sonometrics, Inc. an ultrasound catheter guidance company, where he developed technology that was subsequently acquired by Cardiac Pathways (now Boston Scientific). He is the author of 12 issued patents and over 85 publications.

About ProtomedLabs
ProtomedLabs SASU, France, is an ISO 13485 & 9001 certified single source company which offers responsive turnkey device testing engineering solutions for companies developing implantable and interventional cardiovascular devices. ProtomedLabs SASU provides equipment solutions and contract services to help device manufacturers meet the highest standards in the industry.
www.protomedlabs.com

About ViVitro Labs
ViVitro Labs Inc. offers industry-leading cardiovascular test equipment and related laboratory testing and consulting services. Hundreds of organizations in over 40 countries for over 30 years have trusted ViVitro expertise, accuracy, and quality for their heart valve, LVAD, TAH, stent, and graft testing. ViVitro Laboratory Services holds ISO/IEC 17025 accreditation based on ISO 5840. ViVitro products are manufactured by StarFish Medical. ViVitro’s A2LA Scope of Accreditation includes the physical and mechanical testing of heart valve substitutes.
www.vivitrolabs.com

For more information please contact:

Mike Camplin
mcamplin@vivitrolabs.com
250.388.3531 x210
# # #


Check out developer.linkedin.com! LinkedIn Developer Resources Leverage LinkedIn's APIs to maximize engagement https://developer.linkedin.com https://example.com/logo.png anyone

STAY UPDATED

Sign up for our newsletter today